medicineScienceThe 943-Dimensional Chess of a Trustworthy Covid-19 VaccineBy Adam RogersScienceCould Breathalyzers Make Covid Testing Quicker and Easier?By Keith GilloglyScienceBlood Centers Are Barely Meeting Convalescent Plasma DemandBy Sara HarrisonBusinessAccess to Telemedicine Is Hardest for Those Who Need It MostBy Joanna PearlsteinIdeasThe FDA's Approach to Covid-19 Is a Bloody MessBy Hilda BastianScienceA Postal Slowdown Is Scary for Those Who Get Meds By MailBy Sara HarrisonScienceThe FDA Just OK'd Emergency Use of Plasma for Covid-19By Adam RogersScience97,000 People Got Convalescent Plasma. Who Knows if It Works?By Adam RogersIdeasHydroxychloroquine Is Toast. Now Say Hi to Its 'Dirty' CousinBy Roxanne KhamsiScienceNew Data on How Many Kids Got That Covid Mystery IllnessBy Maryn McKennaScienceCovid-19 Drug Research Is a Big Huge MessBy Adam RogersScienceWhat Poetry Means for Doctors and Patients During a PandemicBy Sara HarrisonScienceWhat Does It Mean to Say a New Drug ‘Works’?By Adam RogersBusinessThis Algorithm Doesn't Replace Doctors—It Makes Them BetterBy Tom SimoniteScienceHydroxychloroquine Still Doesn’t Do Anything, New Data ShowsBy Adam RogersScienceLlamas—Yes, Llamas—Could Help Us Fight Covid-19By Grace HuckinsScienceCovid-19 Immunity May Rely on a Microscopic Helper: T CellsBy Gregory BarberScienceWhere Should Covid-19 Vaccines Be Tested?By Maryn McKennaScienceThe CEO of Novartis on Developing Drugs During a PandemicBy Steven LevyScienceOld Drugs Could Reveal a New Way to Attack the CoronavirusBy Gregory BarberScienceDexamethasone and the Recovery Trial’s High-Speed ScienceBy Adam RogersScienceFDA Revokes Hydroxychloroquine's Emergency Use AuthorizationBy Grace HuckinsThe Big StoryThe Country Is Reopening. I’m Still on LockdownBy Maria StreshinskyScienceThe Dangers of Excluding Women From HIV Prevention Drug TestsBy Michele Cohen MarillMore Stories
.jpg)
